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Abstract
Introduction. Parvovirus B19 (PV B19) is a small, non-enveloped, ss DNA virus with
an icosahedral capsid having a size of 18–26 nm. PV B19 transmits through respiratory
droplets, blood transfusion and nosocomial infections that have also been documented
recently. The virus targets the actively dividing Erythroid Progenitor Cells (EPCs) that
are found in the human bone marrow, fetal liver and human umbilical cord.
Methods. The study was particularly conducted on Sickle Cell Disease (SCD) patients
and focuses on the determination of parvovirus B19 among Bahraini population by
relying on their clinical status. The serological study of PV B19 was performed using
Enzyme Linked Immunosorbent Assay (ELISA) technique and includes 150 SCD patients
and 100 healthy blood donors in which both males and females were employed. The
samples were taken from the emergency unit of Salmania Medical Complex (SMC) and
Ibrahim Khalil Kano Center (IKKC).
Results. Of the 150 SCD patients, 100 were with vaso-occlusive crisis(VOC) and
50 non-vaso-occlusive crisis (NVOC). The three groups showed significantly higher
percentages of PV B19 IgG but the percentage in SCD was relatively high compared
to the control group of age-matched healthy donors – 70% of the VOC patients, 76%
of the NVOC cases and 57% of blood donors were found to be IgG sero-positive.
Discussion and Conclusion. PV B19 is a pathogenic virus and sometimes considered as
life-threatening specifically for those individuals who have SCD due to which a risk of
transient aplastic crisis increases. This virus is only associated with those patients who
have some hematological disorders such as hemolytic anemia and erythro-cytopenia.
An effective screening test must be performed in the future to reduce the risk of PV
B19 infection.
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1. Introduction
Human parvovirus B19 infections are prevalent worldwide; and, many studies con-
firmed its association with Aplastic Crisis (AC) in SCD patients, however, limited data
about the virus prevalence have been published. Likewise, no such studies have been
published for the Bahraini population despite the high burden of SCD in this area.
Therefore, the present studywas planned to analyze the prevalence of PV B19 infection
in selective Bahraini population, hence, forming a platform for better management of
SCD in Bahrain.
PV B19 is a small, non-enveloped, ss DNA virus with an icosahedral capsid having a
size of 18-26nm. The capsid is constituted of 60 structural viral proteins (VP) and are
of two types: a minor structural protein VP1, that makes up about 5% of the capsid
and a major structural protein VP2 that form the bulk of the total capsid composition
(Adamson, 2013) and the genome of the PV B19 contains around 5000 nucleotides.
(Palinski, 2016). An epidemiological survey observed that half of the adult population
has the immunoglobulin antibodies of this virus in their serum (Aminu & Koledade,
2014). PV B19 is the most common source of infection mostly seen after the winter
season. The mode of transmission of infection is the respiratory droplets. However,
some other routes of transmission also exist such as through blood transfusion and
parental transfer. Moreover, some nosocomial infections also give a chance to PV B19
for causing an infection (Moschovi & Vlahopoulos, 2016).
The actively dividing EPCs are in the human bone marrow and liver, PV B19 attacks
on these cells and thus causing erythrocytopenia, decreased erythrocyte production.
The hereditary hematological disorders such as spherocytosis, thalassemia, or SCD in
particular are at risk of transient aplastic crisis if infected by PV B19 (DeBaun & Kirkham,
2012). SCD is caused by the abnormal type of hemoglobin (Hb), hemoglobin S (HbS).
The hemoglobin of red blood cells (RBCs) is distorted as a result of homozygosity for a
mutant gene that causes the normal hemoglobin (HbA) to alter to hemoglobin S. The
SCD condition is created due to less oxygen in which RBCs become rigid and Sickle-
shaped and cannot be able to pass through the small blood capillaries (Li & Karniadakis,
2016). It has been observed that the prevalence of SCD increases the rate of mortality
and morbidity around the world. These disorders increase the risk of transient aplastic
crisis and can be life-threatening if PV B19 is the source of infection (Guillaud & Michel,
2012).
According to the research of Koury (2014), PV B19 is responsible for several disease
conditions, especially in blood-related infections. It has been found that the primary
DOI 10.18502/kls.v4i6.3089 Page 38
Sustainability and Resilience Conference
interest of PV is to replicate in the bone marrow where EPCs is actively dividing (Claros
& Andrades, 2012). As a result of this, the production of erythrocytes is terminated, and
ultimately the hemoglobin concentration becomes reduced. However, the virus shows
an adverse impact on those patients who have another erythrocyte disorders either
acquired or inherited (Rogo & Rezaei, 2014)
2. Methodology
2.1. Study design
It is a prospective study based on the serological findings and Neopterin detection for
the erythrovirus PV B19. The current study focuses on the determination of parvovirus
among Bahraini population. The study was particularly conducted on SCD patients, and
the duration of this research was October (2012) -September (2013).
Three groups have been taken for the serological study of PV B19 among which
100 patients were associated with VOC, and 50 were NVOC and 100 healthy blood
donors in which both the males and females were included. The target population
includes patients from the emergency unit of SMC and IKKC. During the study, some
patient’s samples were excluded because they were non-Bahraini, below 18 years of
age, and they had other hereditary blood disorders such as thalassemia and other
blood abnormalities.
2.2. Sample collection and its processing
The phlebotomist took a sample of 2-3 ml venous blood into the first vacutainer tubes
with an anticoagulant which prevents blood clotting. Ethylene Diamine Tetra-acetic
Acid (EDTA) is used as an anti-coagulant. In the second vacutainer tube, 2-3 ml whole
blood was collected without an anti-coagulant. The purpose of using EDTA is to find
out the Complete Blood Count (CBC), erythrocyte count, Hemoglobin concentration,
and the percentage of the reticulocytes. All these tests were performed on the same
day when the blood sample was collected. The second sample remained untouched
and was allowed to clot. After this, the tube was centrifuged by using Centaur Density
Gradient Centrifugation (CDGC). It was set at 3500 rpm (revolution per minute) and the
tube was centrifuged for only 10 minutes. After 10 minutes, the serum was separated
from the blood and stored at -80 ºC till the process started.
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2.3. Detection of immunoglobulin by using ELISA
ELISA technique was used for the detection of immunoglobulin in human serum or
plasma. Here, two immunoglobulins were found by using the blood sample of patients
infected with PV B19. IgG and IgM were the immunoglobulins detected by using the
Immuno- enzymatic assay. The manufacturer of ELISA was the Nova Tech (Immundi-
agnostica GmbH, Nova Lisa𝑇𝑀 , Germany) and the product number of ELISA which was
used for this procedure is PARG0370/PARM0370.
2.4. Measurement of Neopterin concentration
The concentration of Neopterin (NPT) was also measured from the serum sample of
patients and control samples by using ELISA technique, for 88 SCD vaso-occlusive crisis,
and 32 of the age and gender matching control group. NPT level of SCD vaso-occlusive
crisis patients were correlated to the patients’ laboratory findings. Laboratory tests
for bacterial and viral infections in blood culture, urine culture and respiratory profile
were recorded as (present, absent or not done). For measuring the concentration
of Neopterin, an IBL International GMBH product was used. ELISA is a quantitative
assay utilized for the detection of Neopterin concentration in human serum, urine, and
plasma. The test was performed as per manufacturer’s instructions.
2.5. DNA extraction
The process of DNA extraction was performed by using molecular techniques. For this
purpose, the QIAGEN DNA extraction kit was used which contained two separate kits,
first was QIAamp DNA mini and the second was QIAamp DNA blood mini kit. This kit
was made in Germany in which the extracted DNA was stored for later use at -20 ºC.
2.6. Polymerase chain reaction method (PCR)
It is a technique used for making copies of small segments of DNA. This method was
used to confirm the detection of PV B19, and done according to the protocol illus-
trated by Aebischer and Beer (2014). The samples of SCD patients were screened by
using the consensus PCR assay with the help of primers present in the NS1 gene.
This screening was specifically for the detection of the erythrovirus DNA. Thus, in
the current study, the serological and molecular test were performed, On the other
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hand, Neopterin concentration was only measured from 88 samples of SCD patients
with VOC, and 32 controlled samples. Furthermore, the current study investigated the
circulating genotype of PV B19 among the Bahraini population.
3. Results
In the VOC patients, the age extended from 18 to 68 years whereas, in the NVOC group,
patient’s age ranged from 18-71 years. All patients were Bahrainis only, no other ethnic
group was found. The age range of the control group was 21 to 61 years.
The sample distributionwas also based on gender differences among the population
enrolled in the study. The samples of 51 male patients were found as SCD with VOC
whereas, 32 males were found as SCD with NVOC. Around 49 females were found
as SCA with VOC, and 18 females have SCD with NVOC. It was observed that the
percentageswere same in both themale and female groups i.e. 33.2%. The percentage
for the control group was 33.6 % in which 84 males and 16 females were included.
3.1. Parvovirus antibodies in the serum sample
The samples which showed positive results for PV B19 containing IgG immunoglobulin
were 165 (66%)whereas, 9 (3.6%) samples showed the presence of IgM immunoglob-
ulin. The total number of positive SCD samples was 108 (72%) in which IgG was found.
Among these SCD samples, 70 suffered from VOC and 38 were NVOC samples, and 57
samples were IgG positive from the control group. The comparison showed the impor-
tance of IgG among SCD patients which is commonly known as the anti-parvovirus B19.
In contrast, another anti-parvovirus B19 that is IgM was detected only in 6 samples of
SCD patients with VOC. IgM was not detected in the SCD patients with NVOC. Around
six samples with both the IgG and IgM antibodies showed positive results of PV B19
among which four samples were taken from SCD patients with VOC and two samples
from the control group.
Based on the findings mentioned above, all 250 samples were moved towards the
molecular DNA extraction of PV B19. When PCR was performed, four samples were
found to be positive for DNA presence, two samples from VOC group, one from the
NVOC group, and the last sample was from the control group. The given table was
based on the relationship of parvovirus infection with IgM which is considered as an
anti-parvovirus immunoglobulin. These results were compared by molecular findings
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of genotype with anti-IgM serology. The comparison between SCD patients with VOC,
NVOC and the control group is presented in the table given below (Table 1).
T 1: Molecular detection and response of antibodies in serum samples that showed positive results
of PV B19.










70 (70) 6 (6) 4 (4) 2 (2)
SCD non-
vaso-occlusive crisis
38 (76) 0 (0) 0 (0) 1 (2)
100 control 57 (57) 3 (3) 2 (2) 1 (1)
3.2. Neopterin concentration
Upon comparison between bacterial and viral laboratory findings in SCD vaso-occlusive
crisis patients, it was found that the number of viral infections tested in those patients
were limited, 4 only (5.7 %), but, the NPT concentrations were significantly high
(p=0.037). On the other hand, bacterial testing were more in number 11 (15.7%),
nevertheless, the NPT concentrations were lower. Table 2 shows the comparison
between NPT positive samples of SCD vaso-occlusive
crisis patients and the healthy controls samples, the correlation was significantly
high (p=0.000), as, all control samples were negative for NPT incidence.
T 2: The comparison between NPT positive samples of SCD vaso-occlusive crisis patients and the
healthy controls (p=0.00 by Fisher’s Exact Test).




Positive 80.7 (71) 0 (0)
Negative 19.3 (17) 100 (32)
Total 100 (88) 100 (32)
3.3. PCR results
All the 250 clinical samples were extracted, DNAs from the serum samples were ampli-
fied by PCR using consensus primers. Out of 150 SCD patient 3 (2%), (2 from SCD vaso-
occlusive crisis patients and 1 from SCD non-vaso-occlusive crisis patients) and 1%
(1/100) of the controls recruited for this studywere found positive for viral DNA by PCR.
All the 4 positive samples were subjected to genotyping procedure and the restriction
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digestion revealed 2 bands each for NS1 restriction (36 & 67 bp of the 103 bp uncleaved
fragment and VP1u restriction 149 and 55 bp of the 204 bp uncleaved fragment).
Representative gel electrophoresis for NS1, VP1u bands and their restriction products
were photographed and are shown in (Figs. 1) The 4 positive results were ampli-
fied by nested PCR (Fig. 2) and sent for sequencing. A representative chromatogram
of the sequences received from the Genoscreen is shown as (Fig. 3). Analyses of
our sequences with “Chromas”, “Blast” and “Clustal W” revealed that the sequences
belonged to Genotype 1.
Figure 1: The genotyping and restriction digestion process in which NS1 gene is shown into small segments
known as amplicons. Mfel and Apal restriction enzymes were used for the amplification of DNA. Two
digested segments of NS1 were shown and their size was 67bp and 36bp.
4. Discussion
Parvovirus is a pathogenic virus which is occasionally considered as life-threatening
specifically for those individuals who have SCA due to which a risk of transient aplastic
crisis increases (Turkeltaub & Tyring, 2017). It has an ability to destroy the erythroid
progenitor cells in human and cause destruction of these cells specifically in the bone
marrow which may result in Erythropoiesis (Eaves, 2015). PV B19 was first identified
in 1981 and its association with the disease was reported when a patient of sickle cell
anemia went through transient aplastic crisis (Williams & Jarreau, 2012). However, this
virus is only associated with those patients who have some hematological disorders
such as hemolytic anemia and erythro-cytopenia. Since the detection of erythrovirus,
it has been found that PV B19 is also associated with other diseases including: purpuric
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Figure 2: The sequencing process of amplified segments and the sequences were related to genotype 1.
The sequencing of amplicons was performed for those patients whose test results found positive to PV
B19 by the help of molecular and screening test.
Figure 3: Representative Chromatogram of PV B19 Genotype 1. The figure shows a representative
sequence analyzed using the Chromas software.
eruption on hands and feet in adults, erythema infectiosum, and spontaneous abortion
in pregnant women (Bello & Lapadula, 2013). Moreover, PV B19 increases the risk of
infection in the intrauterine cavity that can cause asymptomatic effects among females
and may also cause several fatal complications (Ornoy & Ergaz, 2017).
Chronic anemia was also reported in some immune-compromised patients and
aplastic crisis in Sickle cell anemic patients (Al-Najjar, 2013). A study was conducted in
the capital of Saudi Arabia at the Armed Forces Hospital (AFH) in March 2001, to find
out the exposure of PV B19 among patients with hemolytic disorders, for this purpose,
lab records of 73 patient’s serum were taken and sent for the detection of IgG and IgM
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by using ELISA technique. The findings revealed that 68% patients showed serological
evidence of PV B19 which was due to previous exposure. The study concluded that
68% of PV B19 infected patients could be considered at risk of chronic hemolytic
disease (Sener & Afsar, 2012).
Parvovirus can cause interruption in the production of RBCs which could be life-
threatening sometimes but not in every case. At the initial stage, it is necessary to
transfuse multiple blood bags so that the patients show recovery within two weeks
(Hess, 2012). IgG and IgM are the two antibodies found in human body against PV
B19 and they are commonly known as the anti-parvovirus immunoglobulin. In the cur-
rent study, these two antibodies were identified by using ELISA. Furthermore, another
molecular method was used for targeting the specific segment of the genome of virus.
This molecular method is known as Polymerase chain reaction (Deng & Wu, 2012). In
the current study, Neopterin level was also found in the serum samples of patients
because it is an inflammatory marker and plays a significant role in the detection of
cellular immune response (Parker & Oh, 2013).
According to the research of Gulf Cooperation Council, it is revealed that many coun-
tries including Saudi Arabia, Bahrain, and Kuwait showed high prevalence of Sickle cell
anemia (Barakat-Haddad, 2013). The current study was conducted in Bahrain where
inherited hemoglobin disorders are frequently reported among which two most com-
monly found are; Sickle cell disease and Thalassemia. According to Tsitsikas and Amos
(2014), SCA patients are found to be more susceptible for the recurrent infection of PV
B19. The prevalence and complications of PV B19 in SCD and thalassemia patients have
been reported around theworld and it needs urgent development and strategieswhich
provide the preventive measures to those patients who have hemolytic disorders
(Chou & Thompson, 2012). These prevention strategies may also require reducing the
burden of life-threatening complications linked with parvovirus infections. Therefore,
routine inspection of the blood samples should be performed either by general screen-
ing method such as by measuring the Neopterin concentration or molecular method
like PCR (Skvarc & Kaasch, 2013).
5. Conclusion
This study reflected the health status of Bahraini population among which high preva-
lence of PV B19 has been found. This study concluded that 70% SCD patients suffered
from vaso-occlusive crisis and 76% patients belonged to non-vaso-occlusive group
patients. Further observation revealed that serological indication of parvovirus was
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also found in high frequency that is 57% in the control group which consisted of
healthy individuals. The current study also observed high frequency of anti-parvovirus
immunoglobulin both in the SCD patients and control group. Among the population of
Bahrain, the identification of IgM was found to be significantly lower as compared to
IgG. Due to the frequency of IgM, the risk of fatal crisis may increase in such ane-
mic patients. After screening of blood donor’s sample, it was concluded that only 3%
donors have IgM antibody which can prevent them from the infection of PV B19. How-
ever, it is observed that just because of inappropriate features of testing, the presence
of parvovirus DNA has been found to be high in the SCD and Thalassemia patients. It
is concluded from the study that an effective screening test must be performed in the
future to reduce the risk of PV B19 infection.
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